Parag Goyal, MD
Advanced Heart Failure and Transplant Cardiology · New York, NYNPI 1528385556
Payments from drug & device makers
Across 287 payments — averaging $3729.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$431K
- E.r. Squibb & Sons, L.L.C.$228K
- Janssen Research & Development, LLC$170K
- AstraZeneca$78K
- Novo Nordisk AS$53K
- Alnylam Pharmaceuticals Inc.$29K
- plus $82K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 3 | $430,502 |
| E.r. Squibb & Sons, L.L.C. | 7 | $228,273 |
| Janssen Research & Development, LLC | 8 | $169,854 |
| AstraZeneca | 15 | $77,843 |
| Novo Nordisk AS | 166 | $53,094 |
| Alnylam Pharmaceuticals Inc. | 21 | $28,743 |
| Ionis Pharmaceuticals, Inc. | 7 | $23,829 |
| Bayer | 19 | $20,922 |
| Pfizer | 8 | $17,112 |
| Bridgebio Pharma, Inc. | 6 | $15,136 |
| Akcea Therapeutics, Inc. | 2 | $2,670 |
| Abbott | 12 | $1,107 |
| Boehringer Ingelheim | 5 | $647 |
| Novartis | 2 | $187 |
| Biosense Webster, Inc. | 1 | $148 |
| Abiomed | 1 | $136 |
| Cvrx, Inc. | 1 | $116 |
| Edwards Lifesciences | 1 | $91 |
| Amgen | 1 | $62 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
How this compares
$1,070,497 in reported general payments places this provider in the 95th percentile of 106 advanced heart failure and transplant cardiology providers in New York.
See all advanced heart failure and transplant cardiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in New York
- Mathew MaurerNew York$5M
- Evelyn HornNew York$2.9M
- Johanna ContrerasNew York$1.4M
- Nir UrielNew York$884K
- Tajinderpal SaraonNew York$618K
- Kelly AxsomNew York$502K
- Sean PinneyNew York$414K
- Yevgeniy BrailovskyNew York$339K
- James YoussefNew York$287K
- Alex ReyentovichNew York$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.